Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
about
Aripiprazole alone or in combination for acute maniaPharmacotherapy of bipolar disorder in children and adolescents: an updateAripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-AnalysisFirst do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents.Treatment of Pediatric Bipolar Disorder: A ReviewTreatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec.Profile of aripiprazole in the treatment of bipolar disorder in children and adolescentsEvidence-based recommendations for monitoring safety of second generation antipsychotics in children and youthAn open-label study of aripiprazole in children with a bipolar disorder.Efficacy and safety of aripiprazole in child and adolescent patientsPsychopharmacology of pediatric bipolar disorder.Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials.Clinical usefulness of second-generation antipsychotics in treating children and adolescents diagnosed with bipolar or schizophrenic disorders.Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.The comorbidity of ADHD and bipolar disorder: any less confusion?Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar I disorder in children and adolescents: a NICE single technology appraisal.Antipsychotics use in children and adolescents: An on-going challenge in clinical practice.Atypical antipsychotics for disruptive behaviour disorders in children and youths.A Pharmacologic Algorithm for Youth Who Are at High Risk for Bipolar Disorder.A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy.Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research.Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder.Aripiprazole in Bipolar Disorder
P2860
Q24201765-8836DAA3-542D-4D88-8F25-5CB6E2C3BD22Q27027052-765371D9-1FC6-4A1F-9AED-C4E779DF1D4CQ28073540-6F60747F-0121-4749-8BA4-9123F58A0596Q33845881-AC6322FF-1290-4587-B526-826B272D21C1Q34206467-2BE20C94-A4BF-460A-A6A1-6F3AB24A4961Q34575069-3A3CB6D2-D16C-4EE9-BAF6-5B78FD4BC0ABQ34600500-455AFFB2-BA8A-41D3-A742-C51BA34C9FDEQ35128405-5C350A2F-6EEF-477D-A2A0-3D504C4AA0D8Q35330010-422660F7-BDA8-4636-A832-597348C61A7FQ36075828-25D67036-5844-4959-9613-2EC52C82D613Q37768441-45F57425-899F-4588-8962-CB19B64DEAB5Q37900615-EDCFD47A-5E4D-489D-8A89-49C7E69656BBQ37925811-DF3F8A8D-1EB6-42AD-B8ED-47977B512E60Q38090490-9A7F3B30-F9B4-4C6D-B4BA-6713083BF358Q38092009-10710D12-D08B-46FD-969A-2301BBF22AD6Q38109854-E46B1F81-6049-40F1-9227-335D45D2067CQ38149091-0F6E72E3-A341-4887-BD7F-4A82D3BCF232Q38217992-955EE2B9-A960-47EB-8D93-6037A3C90CB7Q38632745-A9C1C951-E1F4-44F9-817C-C1D51F1E0BE5Q38653732-FAB8FD84-B745-46C6-AC5F-E11048909431Q38824837-B5261F39-CB60-438E-8648-3375C3A8D9F6Q39285492-49071D99-052E-4982-9790-560B867192BCQ44142664-DE852DC6-F8FA-4B69-8704-E14AD72628E8Q47114336-88BCE804-53DD-40A1-AC80-5A2DEAB90510Q50301292-E17BBFB2-0DD6-4AEA-9166-52463148FCA2Q57612470-BCC2121B-C04B-4143-BFD7-EE99B71FA7EC
P2860
Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Aripiprazole in children and a ...... lot randomized clinical trial.
@en
type
label
Aripiprazole in children and a ...... lot randomized clinical trial.
@en
prefLabel
Aripiprazole in children and a ...... lot randomized clinical trial.
@en
P2093
P921
P356
P1476
Aripiprazole in children and a ...... lot randomized clinical trial.
@en
P2093
Carla R Ketzer
Cristian P Zeni
Gabriel F Pheula
Joana Narvaez
Luis Augusto Rohde
Silzá Tramontina
P304
P356
10.4088/JCP.08M04726
P577
2009-04-21T00:00:00Z